![]() | - SMTL ID
- 5n16.1
- Ligands
- 5-cyclopropyl-2-(5-pyrazin-2-yl-1,2,4-oxadiazol-3-yl)benzo[b][1,4]benzothiazepin-6-one; NICKEL (II) ION
- Polypeptides
- Bromodomain-containing factor 1
- Oligo-state
- monomer
|
![]() | - SMTL ID
- 5n16.2
- Ligands
- NICKEL (II) ION
- Polypeptides
- Bromodomain-containing factor 1
- Oligo-state
- monomer
|
![]() | - SMTL ID
- 5n16.3
- Ligands
- 5-cyclopropyl-2-(5-pyrazin-2-yl-1,2,4-oxadiazol-3-yl)benzo[b][1,4]benzothiazepin-6-one; GLYCEROL; NICKEL (II) ION
- Polypeptides
- Bromodomain-containing factor 1
- Oligo-state
- monomer
|
![]() | - SMTL ID
- 5n16.4
- Ligands
- 5-cyclopropyl-2-(5-pyrazin-2-yl-1,2,4-oxadiazol-3-yl)benzo[b][1,4]benzothiazepin-6-one; NICKEL (II) ION
- Polypeptides
- Bromodomain-containing factor 1
- Oligo-state
- monomer
|